Biocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban Ruchika Sharma16 May 2025 2:57 PM ISTBangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug...
Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year Ruchika Sharma15 May 2025 3:26 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Lupin bags tentative USFDA approval for Rivaroxaban Tablets Ruchika Sharma24 Jan 2024 11:19 AM ISTThis product will be manufactured at Lupin's Pithampur facility in India.
Alembic Pharma gets tentative USFDA nod for Rivaroxaban Tablets Ruchika Sharma23 Jun 2020 11:23 AM ISTThe approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 10 mg, 15 mg, and 20 mg, of Janssen...
